In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
FDA Approves ‘Breakthough’ Drug to Prevent HIV
Related Posts
A team of astronomers has proposed peering into the inconspicuous…
Elizabeth Clare’s airborne eDNA project is a winner of the…